C86.11
BillableHepatosplenic T-cell lymphoma, in remission
HCC Category Mapping
V28HCC 20 — Lung and Other Severe Cancers
0.000V24HCC 10 — Lymphoma and Other Cancers
0.675ESRDHCC 10 — Lymphoma and Other Cancers
0.000RxHCCHCC 21 — Hodgkin Lymphoma and Other Cancers
0.000What This Code Means
A rare lymphoma affecting the liver and spleen caused by abnormal T-cells that is currently in remission.
Coding Tips
- •Confirm remission status is documented before coding
- •Verify involvement of both liver and spleen in the diagnosis
Clinical Significance
Hepatosplenic T-cell lymphoma in remission is a rare clinical achievement given the typically aggressive course of this disease. Remission may be achieved through intensive chemotherapy or stem cell transplantation. Patients require close surveillance due to the high relapse rate, and ongoing monitoring of liver function, spleen size, and peripheral blood counts is essential.
Documentation Requirements
- ✓Remission must be explicitly documented by the treating oncologist with supporting evidence from imaging, laboratory studies, and potentially bone marrow biopsy.
- ✓The original hepatosplenic T-cell lymphoma diagnosis must be confirmed in the medical record.
- ✓Surveillance plan and any transplant-related complications should be documented.
Commonly Confused Codes
C86.10 (hepatosplenic T-cell lymphoma not in remission) indicates active disease.Z85.79 (personal history of malignant neoplasm of lymphoid tissue) is only appropriate when the disease is considered cured.C85.97 (NHL unspecified, spleen) should not be used when the specific hepatosplenic T-cell type is known.
Code Hierarchy
└C86Other specified types of T/NK-cell lymphoma└C86.1Hepatosplenic T-cell lymphoma└C86.11Hepatosplenic T-cell lymphoma, in remission
└C86.11Hepatosplenic T-cell lymphoma, in remission